Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Price / Earnings (ntm)

Acadia Pharmaceutica Price / Earnings (ntm) Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Price / Earnings (ntm) from 2012 to 2012. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
  • Acadia Pharmaceutica Price / Earnings (ntm) for the quarter ending November 11, 2012 was 4.83 a -0.95% decrease of -0.05 year over year
  • Acadia Pharmaceutica Price / Earnings (ntm) for the last 12 months ending November 11, 2012 was 4.83 a -0.95% decrease of -0.05 year over year
  • Acadia Pharmaceutica Annual Price / Earnings (ntm) for 2012 was 4.83 a 6.36% increase of 0.31 from 2011
  • Acadia Pharmaceutica Annual Price / Earnings (ntm) for 2012 was 4.52 a -6.88% decrease of -0.31 from 2011
  • Acadia Pharmaceutica Annual Price / Earnings (ntm) for 2012 was 4.83 a -0.86% decrease of -0.04 from 2011
Other Valuation Metrics:
  • Acadia Pharmaceutica Market Cap for the quarter ending March 03, 2018 was $2,802m a -21.48% decrease of -602m year over year
  • Acadia Pharmaceutica Price / Book for the quarter ending March 03, 2018 was 8.34 a 10.81% increase of 0.90 year over year
  • Acadia Pharmaceutica Enterprise Value for the quarter ending March 03, 2018 was $2,461m a -19.25% decrease of -474m year over year
View Chart On Koyfin

Quarterly ACAD Price / Earnings (ntm) Data

11/20124.83
11/20124.52
11/20124.83
10/20124.88
10/20124.71
10/20124.88
10/20124.52
10/20124.75
10/20124.71
10/20124.98

Annual ACAD Price / Earnings (ntm) Data

20124.83
20124.52
20124.83
20124.88
20124.71
20124.88
20124.52
20124.75
20124.71
20124.98